References

Batki, S.L.  Treatment of intravenous drug users with AIDS: 
The role of methadone maintenance. 
Journal
of Psychoactive Drugs
1988 20: 213-216.



Legal Action Center. Beazer vs New York City Transit
Authority: A Landmark Decision on Methadone Maintenance

[Report].  New York:
National Institute on Drug Abuse, 1975.

 

Des
Jarlais, D.C.; Friedman, S.R.; Novick, D.M. et al.  HIV-1 infection among intravenous drug users in Manhattan. 
Journal
of the American Medical Association
1989 261: 1008-1012.

 

Dole,
V.P.; Nyswander, M.E. Heroin addiction: Metabolic disease. Archives of Internal Medicine
1967 120: 19-24.

 

Dole,
V.P.; Nyswander, M.E.  A
medical treatment for diacetylmorphine (heroin) addiction.  Journal of the American Medical Association 1965 (August 23)
193(8): 646-650.

 

Dole,
V.P.; Nyswander, M.E.; Kreek, M.J. 
Narcotic blockade.  Archives
of Internal Medicine
1966 
(October) 118:304-309.

 

Goldstein,
D.  Personal communication,
Eli Lilly Pharmaceuticals, 1992.

 

Joseph,
H; Springer, E.  Methadone
maintenance treatment and the AIDS epidemic. 
In:  The Effectiveness of Drug Abuse
Treatment: Dutch and American Perspectives
. p 261-274. 
Malabar, Florida: Robert E. Krieger, 1990.

 

Kreek,
M.J.  Health consequences
associated with the use of methadone. 
In:  Cooper, J.R.;
Altman, F.; Brown, B.S.; Czechowicz, D. (eds), Research
on the Treatment of Narcotic Addiction: 
State of the Art
(NIDA Research Monograph 83-1201). 
Rockville, MD: National Institute on Drug Abuse, 1983.

 

Platt,
J.J.  Heroin Addiction: 
Theory, Research and Treatment
. 
Malabar, FL:  Kreiger, 1988. 

 

Sells,
S.B.  Effectiveness of Drug Abuse Treatment:
Volume 1 Evaluation of Treatments
. 
Cambridge:  Ballinger,
1974a.

 

 

Sells,
S.B.  Effectiveness of Drug Abuse Treatment:
Volume 2 Research on Patients, Treatments, and Outcomes
. 
Cambridge:  Ballinger,
1974b.

 

Sells,
S.B; Simpson, D.D. The case for drug abuse treatment effectiveness,
based on the DARP research program. British
Journal of Addiction
1980 75: 117-131.

 

Sells, S.B; Simpson, D.D. Effectiveness
of Drug Abuse Treatment: Volume 3 Further Studies of Drug Users,
Treatment Typologies and Assessment of Outcome During Treatment in the
DARP
.  Cambridge: 
Ballinger, 1976a.

 

Sells, S.B.; Simpson, D.D. 
Effectiveness
of Drug Abuse Treatment: Volume 4 Evaluation of Treatment Outcomes for
the 1971-1972 Admission Cohort
. 
Cambridge:  Ballinger,
1976b.

 

Sells, S.B.; Simpson, D.D. 
Effectiveness
of Drug Abuse Treatment: Volume 5 Evaluation of Treatment Outcomes for
the 1972-1973 Admission Cohort
. 
Cambridge:  Ballinger,
1976c.



Goldstein,
D.  Personal communication,
Eli Lilly Pharmaceuticals, 1992.

 

Joseph,
H; Springer, E.  Methadone
maintenance treatment and the AIDS epidemic. 
In:  The Effectiveness of Drug Abuse
Treatment: Dutch and American Perspectives
. p 261-274. 
Malabar, Florida: Robert E. Krieger, 1990.

 

Kreek,
M.J.  Health consequences
associated with the use of methadone. 
In:  Cooper, J.R.;
Altman, F.; Brown, B.S.; Czechowicz, D. (eds), Research
on the Treatment of Narcotic Addiction: 
State of the Art
(NIDA Research Monograph 83-1201). 
Rockville, MD: National Institute on Drug Abuse, 1983.

 

Platt,
J.J.  Heroin Addiction: 
Theory, Research and Treatment
. 
Malabar, FL:  Kreiger, 1988. 

 

Sells,
S.B.  Effectiveness of Drug Abuse Treatment:
Volume 1 Evaluation of Treatments
. 
Cambridge:  Ballinger,
1974a.

Similar Posts

  • Policy Makers Luncheon

    Admin 11/11/2021

    National Methadone Conference AMTA 2001 Monday, October 8th, 11 am to 1 pm Chair Mark Parrino, American Methadone Treatment Association The Policy Maker’s Luncheon is an invitation only event that is attended by the federal and state agencies and national organizational representatives (i.e. ASAM, NAMA). Therefore no pictures were taken during the luncheon. The Policy…

  • Oral Swabs

    Admin 08/23/2022

    Policy Statement Number 13 July 2003 The development of Oral Swabs for toxicology testing shows potential in providing an alternative means to test for drug use and to assess if a patient is taking their medication as prescribed. Such advances in technology should improve the quality of treatment that programs can provide to patients. However…

  • Stop Stigma Now

    Admin 10/06/2022

    Our Mission Today over a million people in this country are suffering from an addiction to opiates. The fortunate ones are those who have sought treatment… those who take a single dose of medication each day to be free of opiate addiction. It was 50 years ago that a group of three doctors at Rockefeller…

  • |

    Orlaam(LAAM) Alert

    Admin 06/17/2021

    FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434   Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…

  • Basic Pharmacology: How Methadone Works? Part III Drugs and Conditions That Impact On the Action of Methadone by Joycelyn Woods

    Admin 09/16/2021

    Education Series Number 5.3 February 2001 (Revised) Joycelyn Woods has a graduate degree in neuroscience and psychopharmacology. She has published in neuroscience journals and is recognized internationally for her methadone advocacy work. She is a recipient of the “Richard Lane Methadone Advocacy Award.” Methadone Metabolism Methadone was once considered to be pretty much the same…

  • Submit a Concern

    Admin 07/03/2021

    Report a Program for NOT Following Federal Recommended Guidelines, COVID-19 Social Distancing and other Protections (for patients and staff) THIS FORM IS IN BETA AND NOT WORKING AT THIS TIME Program Information Name of Program *Name of Program Program Location * Address of ProgramStreet AddressApt, Suite, Bldg. (optional)CityState / Province / RegionPostal / Zip CodeAfghanistanAlbaniaAlgeriaAndorraAngolaAntigua…